[The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients]
- PMID: 14748265
[The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients]
Abstract
Human parvovirus B19 (PV-B19) infection may lead to very serious clinical situations such as transient aplastic crisis in patients with hemolytic anemia, thrombocytopenia, neutropenia and transient arthritis accompanied with erythema infectiosum, especially in immunosuppressed patients. Early diagnosis of PV-B19 infection is of critical importance especially in immunosuppressed patients since the necessary precautions can be undertaken accordingly. In this study, PV-B19 IgM and IgG antibodies and viral DNA have been searched by enzyme immunoassay (ELISA) and real-time polymerase chain reaction (PCR), respectively, in 50 PV-B19 suspected immunosuppressed patients. Viral IgM, IgG and DNA positivities were detected in 7 (14%), 20 (40%) and 7 (14%) of the patients, respectively. During the first week three patients were found DNA and IgM positive but IgG negative, while four patients were found positive for the viral DNA, IgM and IgGs. The DNA copy numbers were high in all of the patients during the first week, with a gradual decrease during a seven-week follow-up period. IgM antibodies have disappeared in the sixth week in three of the patients and at the end of the seventh week in four of the patients. Although the IgG antibodies were negative in three patients in the first week, they became positive in the second week and the titers gradually increased during the following weeks. According to the results of this study, it can be concluded that, in high risk groups such as immunosuppressed patients, in addition to ELISA, real-time PCR method would be helpful for the early diagnosis of PV-B19 infections.
Similar articles
-
[Detection of human parvovirus B19 DNA using PCR and serological test using ELISA for diagnosis of infection].Rinsho Byori. 1993 Feb;41(2):203-8. Rinsho Byori. 1993. PMID: 8361022 Japanese.
-
[Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].Mikrobiyol Bul. 2007 Oct;41(4):597-602. Mikrobiyol Bul. 2007. PMID: 18173080 Turkish.
-
Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.Pediatr Infect Dis J. 2006 Oct;25(10):898-901. doi: 10.1097/01.inf.0000237865.01251.d2. Pediatr Infect Dis J. 2006. PMID: 17006284
-
[A case of Guillain-Barré syndrome (GBS) following human parvovirus B19 infection].Rinsho Shinkeigaku. 2000 May;40(5):471-5. Rinsho Shinkeigaku. 2000. PMID: 11002730 Review. Japanese.
-
[Parvovirus B19 and pediatric pathology].Arch Pediatr. 1994 May;1(5):508-14. Arch Pediatr. 1994. PMID: 7951839 Review. French.
Cited by
-
Prevalence of Human Parvovirus B19 in Neurological Patients: Findings from Region of Western Saudi Arabia.Curr Health Sci J. 2020 Jan-Mar;46(1):16-22. doi: 10.12865/CHSJ.46.01.03. Epub 2020 Mar 31. Curr Health Sci J. 2020. PMID: 32637161 Free PMC article.
-
Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.Clin Rheumatol. 2016 Oct;35(10):2615-8. doi: 10.1007/s10067-016-3379-6. Epub 2016 Aug 19. Clin Rheumatol. 2016. PMID: 27541023 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical